Obtainment of 177Lu-DOTA-LANREOTIDE for in vivo studies

被引：0
|
作者：
Nevares, Noemi
Jimenez, Yarissa Villareal
Deluca, Gustavo
Zapata, Miguel
Perez, Juan
Rojo, Ana
Crudo, Jose L.
机构：
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
10.1016/j.nucmedbio.2010.04.074
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：697 / 697
页数：1
相关论文
共 50 条
  • [1] 177Lu-DOTA-lanreotide:: A novel tracer as a targeted agent for tumor therapy
    Banerjee, S
    Das, T
    Chakraborty, S
    Samuel, G
    Korde, A
    Srivastava, S
    Venkatesh, M
    Pillai, MRA
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (06) : 753 - 759
  • [2] Supported liquid membrane extraction of 177Lu(III) with DEHPA and its application for purification of 177Lu-DOTA-lanreotide
    Kumric, Ksenija
    Trtic-Petrovic, Tatjan
    Koumarianou, Eftichia
    Archimandritis, Spyridon
    Comor, Jozef J.
    SEPARATION AND PURIFICATION TECHNOLOGY, 2006, 51 (03) : 310 - 317
  • [3] Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide
    Heute, D. R.
    Dobrozemsky, G.
    Traub, T.
    Warwitz, B.
    von Guggenberg, E.
    Gabriel, M.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S202
  • [4] Dosimetric studies in normal mice of 177Lu-DOTA-SP and 177Lu-DOTA-His2-MG
    Puerta Yepes, Nancy
    Lopez Bularte, Ana C.
    Nevares, Noemi
    Zapata, Miguel
    Perez, Juan
    Rojo, Ana
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 724 - 724
  • [5] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Heribert Hänscheid
    Philipp E. Hartrampf
    Andreas Schirbel
    Andreas K. Buck
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2566 - 2572
  • [6] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Haenscheid, Heribert
    Hartrampf, Philipp E.
    Schirbel, Andreas
    Buck, Andreas K.
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (08) : 2566 - 2572
  • [7] Radiolabeling of neurotensin agonist and antagonist with 177Lu: bioafinity of 177Lu-DOTA-NT and 177Lu-DOTA-SR48692 to neurotensin receptors
    Lungu, Valeria
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 691 - 691
  • [8] Influence of DOTA chelators on radioimmunotherapy of 177Lu-DOTA-Rituximab
    Wojdowska, Wioletta
    Karczmarczyk, Urszula
    Balogh, Lajos
    Mikolajczak, Renata
    Maurin, Michal
    Postenyi, Zita
    Kovacs-Haasz, Veronika
    Polyak, Andras
    Garnuszek, Piotr
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S368 - S368
  • [9] Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
    Liu, Zheng
    Schaap, Kevin
    Rohde, Martin
    Oehlke, Elisabeth
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S462 - S462
  • [10] Preparation and biodistribution studies of folate receptor targeting 177Lu-labelled folate dimer: 177Lu-DOTA-FA2
    Shao, Guoqiang
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345